ASN007

ASN007 Suppliers list
Company Name: Nantong HI-FUTURE Biology Co., Ltd.
Tel: +undefined18051384581
Email: sales@chemhifuture.com
Products Intro: Product Name:ASN007(ERAS 007)
CAS:2055597-12-9
Purity:0.98 Package:5mg,10mg,100mg,500mg,1g,5g,10g
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354
Email: support@targetmol.com
Products Intro: Product Name:ERK-IN-3;ASN007 free base
CAS:2055597-12-9
Package:10 mg;2 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:ASN007
CAS:2055597-12-9
Purity:99% Package:$71.9/1mg;$150.9/5mg;$250.9/10mg;$550.9/25mg;$950.9/50mg;$1550.9/100mg;Bulk pack Remarks:99%
Company Name: WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.  
Tel: 17702719238 17702719238
Email: sales@sun-shinechem.com
Products Intro: Product Name:ASN007
CAS:2055597-12-9
Purity:98% HPLC Package:50.0mg;100.0mg; 200.0mg;500mg;1g;5g; 10g
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185
Email: sales-cpd@caerulumpharma.com
Products Intro: Product Name:ASN007
CAS:2055597-12-9
Purity:98% Package:1g;10g;100g
ASN007 Basic information
Product Name:ASN007
Synonyms:ASN007;ASN007 free base;N-[(1S)-2-amino-1-(3-chloro-5-fluorophenyl)ethyl]-1-{5-methyl-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1H-imidazole-4-carboxamide;ERK-IN-3;ASN007(ERAS 007);ERK1/2,inhibit,ERK,Inhibitor,ERK IN 3,RAS,Extracellular signal regulated kinases,cancer,ERKIN3;1H-Imidazole-4-carboxamide, N-[(1S)-2-amino-1-(3-chloro-5-fluorophenyl)ethyl]-1-[5-methyl-2-[(tetrahydro-2H-pyran-4-yl)amino]-4-pyrimidinyl]-
CAS:2055597-12-9
MF:C22H25ClFN7O2
MW:473.93
EINECS:
Product Categories:
Mol File:2055597-12-9.mol
ASN007 Structure
ASN007 Chemical Properties
density 1.48±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 250 mg/mL (527.50 mM; Need ultrasonic)
form Solid
pka12.73±0.46(Predicted)
color White to light yellow
Safety Information
MSDS Information
ASN007 Usage And Synthesis
Biological ActivityERK-IN-3 is a potent and orally active inhibitor of ERK. ERK-IN-3 inhibits ERK1/2 with low single-digit nM IC50 values. ERK-IN-3 can be used for the research of cancers driven by RAS mutations[1]. ERK-IN-3 inhibits the phosphorylation of ERK1/2 substrates such as RSK1, FRA1, and Elk1 in various cell lines[1].ERK-IN-3 showes single-digit nanomolar antiproliferative activity that is selective for MAPK-pathway dependent cancer cell lines[1]. ERK-IN-3 (daily p.o.) inhibits tumor growth in multiple BRAF and KRAS mutant xenograft models in mice and was well tolerated at efficacious doses[1].
References[1]. Sanjeeva PR, et, al. Abstract B150: ASN007, a novel oral ERK inhibitor, shows robust antitumor activity in RAS mutant cancer models. Molecular Cancer Therapeutics. 2018 Jan; 17(1).
ASN007 Preparation Products And Raw materials
Tag:ASN007(2055597-12-9) Related Product Information